Abstract
Previous studies have reported changes in white matter microstructures in patients with insomnia. However, few neuroimaging studies have focused specifically on white matter tracts in insomnia patients after having received treatment. In this prospective study, diffusion-tensor imaging was used in two samples of heart-kidney imbalance insomnia patients who were treated with placebo or Jiao-Tai-Wan, a traditional Chinese medicine commonly used to treat heart-kidney imbalance insomnia, to assess the changes in white matter tracts. Tract-based spatial statistical analyses were first applied to compare the changes in mean diffusivity and fractional anisotropy of white matter between 75 heart-kidney imbalance insomnia patients and 41 healthy control participants. In subsequent randomized, double-blind, placebo-controlled trials, comparisons of mean diffusivity and fractional anisotropy were also performed in 24 heart-kidney imbalance insomnia patients (8 males; 16 females; 42.5 ± 10.4 years) with Jiao-Tai-Wan and 26 heart-kidney imbalance insomnia patients (11 males; 15 females; 39.7 ± 9.4 years) with a placebo, with age and sex as covariates. Fractional anisotropy values in left corticospinal tract were increased in heart-kidney imbalance insomnia patients. Heart-kidney imbalance insomnia patients showed lower mean diffusivity and fractional anisotropy values of several white matter tracts than healthy control participants, such as the bilateral anterior limb of internal capsule, bilateral superior longitudinal fasciculus and bilateral posterior corona radiata. After being treated with Jiao-Tai-Wan, heart-kidney imbalance insomnia patients showed a trend towards reduced fractional anisotropy values in the left corticospinal tract. Jiao-Tai-Wan may improve the sleep quality by reversing the structural changes of the left corticospinal tract caused by heart-kidney imbalance insomnia.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Insomnia is one of the most prevalent subjective complaints of sleep-disordered patients worldwide, and it is reported that approximately 4–20% of the population suffers from insomnia (Morin et al. 2011; D. Riemann et al. 2011; Roth et al. 2011). The main characteristic of insomnia is that people with insomnia usually have chronic difficulty falling asleep, difficulty staying sleep, and/or early morning awakening. Insomnia is associated with an increased risk of psychiatric disorders and the quality of an affected patient’s life is severely reduced (Baglioni et al. 2011; Kyle et al. 2010; Morin et al. 2015). Moreover, chronic insomnia is a predisposing factor for type II diabetes, metabolic syndrome and cardio-cerebrovascular diseases (Knutson et al. 2007; M. Li et al. 2014). Although numerous studies have focused on insomnia, the mechanisms underlying the occurrence of insomnia remain poorly understood. Insomnia is often accompanied by other somatic symptoms. These signs and symptoms are diverse and reflect the malfunctioning or imbalance of various body systems, which could be either causes or consequences of insomnia. According to the signs and symptoms of patients, traditional Chinese medicine divides insomnia into many different patterns. The heart-kidney imbalance is one of the main patterns, often accompanied by red tongue, thin coating, fine and rapid pulse, dizziness, tinnitus, seminal emission, night sweating and so on. (Poon et al. 2012).
Current guidelines set cognitive behavioral therapy for insomnia as the preferred treatment for patients who suffer from insomnia (Buysse. 2013; Schutte-Rodin et al. 2008). However, poor adherence may diminish its therapeutic effect (Matthews et al. 2013). Many people cannot address their insomnia without taking a combination of medications. Besides, most therapies only transiently alleviate the symptoms of insomnia instead of delivering a complete cure. The most widely used medications for insomnia are benzodiazepines and benzodiazepine receptor agonists (Buysse. 2013). Still, these therapies incur numerous side effects, including depression, poor memory or forgetfulness, drowsiness and impaired work productivity. In addition, their use is heavily limited by developed tolerance and increased dependency with long-term treatment (Buysse. 2013; Dieter Riemann et al. 2015). So far, guidance for clinicians in choosing the best treatment remains limited, and the search for better treatments is underway. In recent years, increasing evidence has shown that traditional Chinese medicine can be effectively applied in the treatment of insomnia (Singh and Zhao, 2017; Yeung et al. 2012; Zhang et al. 2019). It was reported that Jiao-tai-wan (JTW), made of Rhizome Coptidis and Cortex Cinnamomi at a ratio of 10:1, has a remarkable effect in treating of insomnia linked to an incompatibility between heart and kidney (Huang et al. 2020; Sun et al. 2020; Yue et al. 2016). Experimental studies have shown that JTW can not only regulate levels of neurotransmitters in the blood, such as orexin A (brain tissue), 5-hydroxy tryptamine and γ-aminobutyric acid, which are all therapeutic targets for insomnia (Abad and Guilleminault, 2018; Huang et al. 2020), but it may also regulate immune cytokines, such as interleukin-6 and tumor necrosis factor, which are upregulated by sleep loss (Zou et al. 2017).
Diffusion-tensor imaging (DTI) is a non-invasive method which is widely used to assess alterations in white matter integrity. The decrease of fractional anisotropy (FA) value means the destruction of white matter integrity. Although several studies have investigated white matter structures in people with insomnia, the results of these studies remained inconsistent. For instance, Spiegelhalder et al. (Spiegelhalder et al. 2014) reported a reduced white matter integrity of bilateral anterior internal capsule in primary insomnia, while Bresser et al. (Bresser et al. 2020) only found decreased FA values in the right limb of the anterior internal capsule. Kang et al. (Kang et al. 2018) showed low white-matter integrity between the inferior frontal gyrus and left thalamus in insomnia patients. Li et al. (S. Li et al. 2002). Finally, a tensor model was fitted locally to each voxel using DTIfit (FSL) and maps of FA and MD were calculated.
Tract-based spatial statistics —The voxel-wise statistical analysis of DTI data was based on tract-based spatial statistics (TBSS) from the FMRIB Software Library (S. M. Smith et al. 2006). The FA images from all subjects (n = 116) were aligned to a common target FA image (1 × 1 × 1 mm3 MNI152 FMRIB58_FA standard space) using a non-linear registration. Next, a mean FA image was created and a mean FA skeleton map thresholded to the standard value of 0.2 was generated, representing the centers of all tracts. Subsequently, each participant’s aligned FA images were projected onto the mean FA skeleton for statistical analysis. For better assessment, a TBSS analysis was repeated for MD maps.
Statistical analysis
Differences in age, PSQI and objective sleep measures on polysomnography between HKIIPs and HCs, JTW and placebo group were analyzed by two-sample, two-tailed t tests. Differences in the proportion of females and males between above groups were determined by a two- tailed Pearson χ2 test. Differences in clinical efficacy of medication between JTW and placebo group were assessed by ANCOVA.
A white-matter statistical analysis (covarying for age and sex) was firstly conducted using a general linear model in the FSL randomize tool. Then, 5000 permutation analysis of linear models were carried out with MATLAB software. Finally, threshold-free cluster enhancement (TFCE) was applied to define significant clusters (p < 0.05) and correct multiple comparisons for family-wise error (FWE). Cluster-correction (CC, p < 0.01 and a minimum cluster size of 50 voxels) was used, when FWE correction showed no significant clusters. The Johns Hopkins University (JHU) ICBM-DTI81 White Mater Labels and JHU white-matter tractography atlas were used to locate the specific fibers.
Results
Demographic characteristics
Table 1 presents the characteristics of the participants in this study. The differences between HC group and HKIIPs group were not significantly different for age (p = 0.641) or sex distribution (p = 0.816). Furthermore, HKIIPs had higher PSQI scores than HC participants (12.5±3.0 versus. 2.9±1.4; p < 0.001).
Whole brain white matter difference
Comparison between HCs and HKIIPs
As shown in Fig. 2 and Table 2, the tract-based spatial statistics analysis demonstrated that when compared with HCs, HKIIPs showed significantly higher FA values in the left corticospinal tract (CST) (Fig. 2A, FWE, p < 0.05 ), and significantly lower FA values in several other white matter tracts, including the bilateral superior longitudinal fasciculus (SLF), bilateral anterior limb of internal capsule (ALIC), bilateral anterior and posterior corona radiata (ACR and PCR), bilateral body of corpus callosum (BCC), left cingulum, left posterior thalamic radiation (PTR), right superior corona radiata (SCR), and right CST (Fig. 2B, FWE, p < 0.05). In addition, the tract-based spatial statistics analysis showed lower MD values in HKIIPs at several fibers, such as bilateral SLF, bilateral PCR, bilateral cingulum, bilateral cerebral peduncle, bilateral CST, bilateral ALIC, bilateral posterior limb of internal capsule, bilateral PTR, bilateral SCR, left ACR, and left BCC (Fig. 2C, FWE, p < 0.05).
Clinical efficacy after medication
The characteristics of the JTW group and the placebo group are shown in Table 1. There were no significant differences in gender, age, PSQI score or PSG between the two groups at baseline. PSQI and PSG regulated by ANCOVA were showed in Table 3. PSQI score of HKIIPs decreased significantly after treatment with JTW, but no changes were observed for PSG. Additionally, in Fig. 2D, HKIIPs showed decreased FA values in the left CST after JTW treatment, while the white matter structure of the placebo group remained unchanged (CC, p < 0.01 and cluster size > 50 voxels).
Discussion
Previous studies mainly focused on the changes of white matter in patients with primary insomnia. In this study, we assessed the differences in white matter integrity between HKIIPs and HCs, in addition to the curative effect of JTW on white matter integrity in HKIIPs.
Analysis of white matter changes in HKIIPs
Our findings showed increased FA values in the left CST of HKIIPs compared with HCs. We speculate that this may be associated with increased cortical excitability. The hyperarousal theory of insomnia assumes that increased cognitive and physiological arousal leads to difficulty in initiating or maintaining sleep (Perlis et al. 1997). A study of cortical excitability indicated that chronic insomnia patients showed a globally increased excitability, with larger motor evoked potential sizes to stimulation compared with control participants (van der Werf et al. 2010). In addition, it is reported that a lower corticospinal excitability is related to a smaller CST volume (Lepley et al. 2020). Considering that the CST is of paramount importance in the somatic motor system and increased FA values can be attributable to improved axon density and fiber coherence, we boldly speculated that the increased FA of CST in patients with insomnia was associated with increased cortical excitability. Autonomic, neuroendocrine, electrophysiological, neuroimmunological and neuroimaging findings confirm increased arousal levels in patients with primary insomnia (Bonnet and Arand, 2010; D. Riemann et al. 2010). Insomniacs showed nocturnal elevations of norepinephrine (M. Irwin et al. 2003). Norepinephrine not only has neuroprotective and anti-inflammatory effects, but also can promote the differentiation of oligodendrocytes, and then promote the formation of myelin (Galea et al. 2003; Ghiani et al. 1999; Madrigal et al. 2007). With the formation of myelin, the FA value of neural fibers may increase (Beaulieu. 2002). Conversely, our study also found that the FA and MD values of a large number of fiber bundles in bilateral brain were decreased in HKIIPs. One possible explanation for our findings is the presence of insomnia-associated neuroinflammation involving white matter. A meta-analysis showed that insomnia is associated with increased systemic inflammation markers (M. R. Irwin et al. 2016). In addition, the proinflammatory interleukin IL-6 was highly expressed in the brain of sleep-disordered mice (Zhu et al. 2012). Higher levels of circulating inflammatory markers are correlated with lower FA values in the brain (Rodrigue et al. 2019). Neuroinflammation and low FA values have also been reported in mouse models of craniocerebral trauma (Missault et al. 2019). Thus, we believe that the decrease in FA and MD in the white matter of HKIIPs may be due to neuroinflammation. It is worth noting that the FA values of bilateral CST in HKIIPs showed inconsistent trends, whereby the FA value of right CST was decreased, while the left showed the opposite pattern. This may be due to the fact that the amount by which the FA value increased, due to the excitability in the dominant hemisphere, was much greater than the amount by which it decreased due to neuroinflammation.
The therapeutic effect of JTW
We found that the FA value in the left CST was decreased in HKIIPs after JTW treatment. This may be attributed to the central inhibitory effect of JTW leading to decreased cortical excitability. JTW antagonizes central excitability by regulating the levels of various neurotransmitters and hormones associated with insomnia (Sun et al. 2020). It plays a sedative and hypnotic role by increasing gamma-aminobutyric acid content and receptor expression in the brain of rats. It also increases the level of 5-hydroxytryptamine and decreases the level of norepinephrine in the brain by inhibiting the hypothalamic–pituitary–adrenal axis (HPA) of insomnia rats, thus exerting its therapeutic effect on insomnia (Huang et al. 2020). Our findings may serve to elucidate the underlying therapeutic mechanism of JTW.
PSQI and PSG results
The PSQI score of HKIIPs decreased significantly after treatment with JTW, reflecting the effectiveness of JTW in treating insomnia. The PSQI score was used to assess sleep quality and severity of sleep disorders in the past one month, while the PSG was mainly used to identify the sleep phases, such as REM, NREM, and wakefulness (Chen et al. 2018; Zeng et al. 2020). The PSG results showed no significant difference between the JTW and placebo groups after treatment, which could be due to the little effect of JTW on the sleep structure, or short-term treatment that has no effect on the structure of sleep. Better results might be got if giving a longer course of treatment.
Limitations
This study has several limitations. Firstly, the sample size for the HKIIPs was too small. Secondly, the duration of treatment was not long enough, which may lead to no difference in PSG changes between JTW and placebo after treatment.
Conclusion
Our study demonstrates that JTW treatment for one week did not affect objective sleep measures while the effects on subjective measures deserve further research. The FA value of multiple white matter in the whole brain of the HKIIPs decreased, while the FA value of the left CST increased. After one week of JTW treatment, the increased FA value of left CST decreased.
References
Abad, V. C., & Guilleminault, C. (2018). Insomnia in Elderly Patients: Recommendations for Pharmacological Management. Drugs Aging, 35, 791–817.
Baglioni, C., Battagliese, G., Feige, B., Spiegelhalder, K., Nissen, C., Voderholzer, U., Lombardo, C., & Riemann, D. (2011). Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies. J Affect Disord, 135, 10–19.
Beaulieu, C. (2002). The basis of anisotropic water diffusion in the nervous system - a technical review. NMR Biomed, 15, 435–455.
Bonnet, M. H., & Arand, D. L. (2010). Hyperarousal and insomnia: state of the science. Sleep Med Rev, 14, 9–15.
Bresser, T., Foster-Dingley, J. C., Wassing, R., Leerssen, J., Ramautar, J. R., Stoffers, D., Lakbila-Kamal, O., van de Heuvel, M. P., & Van Someren, E. J. W. (2020). Consistent altered internal capsule white matter microstructure in insomnia disorder. Sleep.
Buysse, D. J. (2013). Insomnia. JAMA, 309, 706–716.
Buysse, D. J., Reynolds 3rd, C. F., Monk, T. H., Berman, S. R., & Kupfer, D. J. (1989). The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res, 28, 193–213.
Chen, D., Yin, Z., & Fang, B. (2018). Measurements and status of sleep quality in patients with cancers. Support Care Cancer, 26, 405–414.
Galea, E., Heneka, M. T., Dello Russo, C., & Feinstein, D. L. (2003). Intrinsic regulation of brain inflammatory responses. Cell Mol Neurobiol, 23, 625–635.
Ghiani, C. A., Eisen, A. M., Yuan, X., DePinho, R. A., McBain, C. J., & Gallo, V. (1999). Neurotransmitter receptor activation triggers p27(Kip1 )and p21(CIP1) accumulation and G1 cell cycle arrest in oligodendrocyte progenitors. Development, 126, 1077–1090.
Huang, Y. F., Bi, X. N., Zheng, W., Zhang, T., Wei, G. J., Zhang, Y. J., & Wang, Q. (2020). Regulatory effect of Jiaotai Pills on central and peripheral neurotransmitters in rats with heart-kidney imbalance insomnia. Zhongguo Zhong Yao Za Zhi, 45, 2172–2179.
Irwin, M., Clark, C., Kennedy, B., Christian Gillin, J., & Ziegler, M. (2003). Nocturnal catecholamines and immune function in insomniacs, depressed patients, and control subjects. Brain, Behavior, and Immunity, 17, 365–372.
Irwin, M. R., Olmstead, R., & Carroll, J. E. (2016). Sleep Disturbance, Sleep Duration, and Inflammation: A Systematic Review and Meta-Analysis of Cohort Studies and Experimental Sleep Deprivation. Biol Psychiatry, 80, 40–52.
Kang, J. M. K., Joo, S. W. J., Son, Y. D. S., Kim, H. K., Ko, K. P. K., Lee, J. S. L., & Kang, S. G. K. (2018). Low white-matter integrity between the left thalamus and inferior frontal gyrus in patients with insomnia disorder. J Psychiatry Neurosci, 43, 366–374.
Knutson, K. L., Spiegel, K., Penev, P., & Van Cauter, E. (2007). The metabolic consequences of sleep deprivation. Sleep Med Rev, 11, 163–178.
Kyle, S. D., Morgan, K., & Espie, C. A. (2010). Insomnia and health-related quality of life. Sleep Med Rev, 14, 69–82.
Lepley, A. S., Ly, M. T., Grooms, D. R., Kinsella-Shaw, J. M., & Lepley, L. K. (2020). Corticospinal tract structure and excitability in patients with anterior cruciate ligament reconstruction: A DTI and TMS study. Neuroimage Clin, 25, 102157.
Li, M., Zhang, X. W., Hou, W. S., & Tang, Z. Y. (2014). Insomnia and risk of cardiovascular disease: a meta-analysis of cohort studies. Int J Cardiol, 176, 1044–1047.
Li, S., Tian, J., Bauer, A., Huang, R., Wen, H., Li, M., Wang, T., **a, L., & Jiang, G. (2016). Reduced Integrity of Right Lateralized White Matter in Patients with Primary Insomnia: A DiffusionTensor Imaging Study. Radiology, 280, 520–528.
Madrigal, J. L., Kalinin, S., Richardson, J. C., & Feinstein, D. L. (2007). Neuroprotective actions of noradrenaline: effects on glutathione synthesis and activation of peroxisome proliferator activated receptor delta. J Neurochem, 103, 2092–2101.
Matthews, E. E., Arnedt, J. T., McCarthy, M. S., Cuddihy, L. J., & Aloia, M. S. (2013). Adherence to cognitive behavioral therapy for insomnia: a systematic review. Sleep Med Rev, 17, 453–464.
Missault, S., Anckaerts, C., Blockx, I., Deleye, S., Van Dam, D., Barriche, N., De Pauw, G., Aertgeerts, S., Valkenburg, F., De Deyn, P. P., Verhaeghe, J., Wyffels, L., Van der Linden, A., Staelens, S., Verhoye, M., & Dedeurwaerdere, S. (2019). Neuroimaging of Subacute Brain Inflammation and Microstructural Changes Predicts Long-Term Functional Outcome after Experimental Traumatic Brain Injury. J Neurotrauma, 36, 768–788.
Morin, C. M., Drake, C. L., Harvey, A. G., Krystal, A. D., Manber, R., Riemann, D., & Spiegelhalder, K. (2015). Insomnia disorder. Nat Rev Dis Primers, 1, 15026.
Morin, C. M., LeBlanc, M., Belanger, L., Ivers, H., Merette, C., & Savard, J. (2011). Prevalence of insomnia and its treatment in Canada. Can J Psychiatry, 56, 540–548.
Perlis, M. L., Giles, D. E., Mendelson, W. B., Bootzin, R. R., & Wyatt, J. K. (1997). Psychophysiological insomnia: the behavioural model and a neurocognitive perspective. J Sleep Res, 6, 179–188.
Poon, M. M., Chung, K. F., Yeung, W. F., Yau, V. H., & Zhang, S. P. (2012). Classification of insomnia using the traditional chinese medicine system: a systematic review. Evid Based Complement Alternat Med, 2012, 735078.
Riemann, D., Nissen, C., Palagini, L., Otte, A., Perlis, M. L., & Spiegelhalder, K. (2015). The neurobiology, investigation, and treatment of chronic insomnia. The Lancet Neurology, 14, 547–558.
Riemann, D., Spiegelhalder, K., Espie, C., Pollmacher, T., Leger, D., Bassetti, C., & van Someren, E. (2011). Chronic insomnia: clinical and research challenges--an agenda. Pharmacopsychiatry, 44, 1–14.
Riemann, D., Spiegelhalder, K., Feige, B., Voderholzer, U., Berger, M., Perlis, M., & Nissen, C. (2010). The hyperarousal model of insomnia: a review of the concept and its evidence. Sleep Med Rev, 14, 19–31.
Rodrigue, A. L., Knowles, E. E., Mollon, J., Mathias, S. R., Koenis, M. M., Peralta, J. M., Leandro, A. C., Fox, P. T., Sprooten, E., Kochunov, P., Olvera, R. L., Duggirala, R., Almasy, L., Curran, J. E., Blangero, J., & Glahn, D. C. (2019). Evidence for genetic correlation between human cerebral white matter microstructure and inflammation. Hum Brain Mapp, 40, 4180–4191.
Roth, T., Coulouvrat, C., Hajak, G., Lakoma, M. D., Sampson, N. A., Shahly, V., Shillington, A. C., Stephenson, J. J., Walsh, J. K., & Kessler, R. C. (2011). Prevalence and perceived health associated with insomnia based on DSM-IV-TR; International Statistical Classification of Diseases and Related Health Problems, Tenth Revision; and Research Diagnostic Criteria/International Classification of Sleep Disorders, Second Edition criteria: results from the America Insomnia Survey. Biol Psychiatry, 69, 592–600.
Schutte-Rodin, S., Broch, L., Buysse, D., Dorsey, C., & Sateia, M. (2008). Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med, 4, 487–504.
Seow, L. S. E., Verma, S. K., Mok, Y. M., Kumar, S., Chang, S., Satghare, P., Hombali, A., Vaingankar, J., Chong, S. A., & Subramaniam, M. (2018). Evaluating DSM-5 Insomnia Disorder and the Treatment of Sleep Problems in a Psychiatric Population. J Clin Sleep Med, 14, 237–244.
Sexton, C. E., Zsoldos, E., Filippini, N., Griffanti, L., Winkler, A., Mahmood, A., Allan, C. L., Topiwala, A., Kyle, S. D., Spiegelhalder, K., Singh-Manoux, A., Kivimaki, M., Mackay, C. E., JohansenBerg, H., & Ebmeier, K. P. (2017). Associations between self-reported sleep quality and white matter in community-dwelling older adults: A prospective cohort study. Hum Brain Mapp, 38, 5465–5473.
Singh, A., & Zhao, K. (2017). Treatment of Insomnia With Traditional Chinese Herbal Medicine. Int Rev Neurobiol, 135, 97–115.
Smith, S. M. (2002). Fast robust automated brain extraction. Human Brain Map**, 17, 143–155.
Smith, S. M., Jenkinson, M., Johansen-Berg, H., Rueckert, D., Nichols, T. E., Mackay, C. E., Watkins, K. E., Ciccarelli, O., Cader, M. Z., Matthews, P. M., & Behrens, T. E. (2006). Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage, 31, 1487–1505.
Spiegelhalder, K., Regen, W., Prem, M., Baglioni, C., Nissen, C., Feige, B., Schnell, S., Kiselev, V. G., Hennig, J., & Riemann, D. (2014). Reduced anterior internal capsule white matter integrity in primary insomnia. Hum Brain Mapp, 35, 3431–3438.
Sun, Y., Yang, Y. H., Wang, J., Jiang, H. Q., Cui, N., Su, B. Z., & Yu, Z. Y. (2020). Review of chemical constituents, pharmacological effects and clinical applications of Jiaotai Pills and predictive analysis of its quality marker(Q-marker). Zhongguo Zhong Yao Za Zhi, 45, 2784–2791.
van der Werf, Y. D., Altena, E., van Dijk, K. D., Strijers, R. L., De Rijke, W., Stam, C. J., & van Someren, E. J. (2010). Is disturbed intracortical excitability a stable trait of chronic insomnia? A study using transcranial magnetic stimulation before and after multimodal sleep therapy. Biol Psychiatry, 68, 950–955.
Yeung, W. F., Chung, K. F., Poon, M. M., Ho, F. Y., Zhang, S. P., Zhang, Z. J., Ziea, E. T., & Wong Taam, V. (2012). Prescription of chinese herbal medicine and selection of acupoints in pattern-based traditional chinese medicine treatment for insomnia: a systematic review. Evid Based Complement Alternat Med, 2012, 902578.
Yue, H., Zhou, X. Y., Li, C. Y., Zou, Z. J., Wang, S. M., Liang, S. W., & Gong, M. J. (2016). Intervention effects of Jiaotai pills on PCPA-induced insomnia in rats. Zhongguo Zhong Yao Za Zhi, 41, 3451–3456.
Zeng, C., Liu, X., Hu, L., Feng, Y., **a, N., Zeng, H., Luo, L., Ye, R., & Yuan, Z. (2020). Jiao-tai-wan for insomnia symptoms caused by the disharmony of the heart and kidney: a study protocol for a randomized, double-blind, placebo-controlled trial. Trials, 21, 408.
Zhang, H., Liu, P., Wu, X., Zhang, Y., & Cong, D. (2019). Effectiveness of Chinese herbal medicine for patients with primary insomnia: A PRISMA-compliant meta-analysis. Medicine (Baltimore), 98, e15967.
Zhu, B., Dong, Y., Xu, Z., Gompf, H. S., Ward, S. A., Xue, Z., Miao, C., Zhang, Y., Chamberlin, N. L., & **e, Z. (2012). Sleep disturbance induces neuroinflammation and impairment of learning and memory. Neurobiol Dis, 48, 348–355.
Zou, X., Huang, W., Lu, F., Fang, K., Wang, D., Zhao, S., Jia, J., Xu, L., Wang, K., Wang, N., & Dong, H. (2017). The effects of Jiao-Tai-Wan on sleep, inflammation and insulin resistance in obesityresistant rats with chronic partial sleep deprivation. BMC Complement Altern Med, 17, 165.
Acknowledgments
We would like to thank Editage (www.editage.cn) for English language editing.
Availability of data and materials
The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.
Code availability
Not applicable.
Funding
This study was funded by the National Natural Science Foundation of China (grant no. 81673733); by the Basic Research Project of Wenzhou(Y2020793), China; by the Basic Research Project of Wenzhou(Y2020794), China; by the Health Foundation for Creative Talents in Zhejiang Province (2016), China; and by Project Foundation for the College Young and Middle-aged Academic Leaders of Zhejiang Province (2017), China.
Author information
Authors and Affiliations
Contributions
Author contributions included conception and study design (QH and ZZY), data collection or acquisition (CYW, TYX, YDZ, MMJ, YLX, MYZ, CYZ, YJY), statistical analysis (JC and TYX), interpretation of results (JC, QH and YXL), drafting the manuscript work or revising it critically for important intellectual content (JC, YXL and NZX) and approval of final version to be published and agreement to be accountable for the integrity and accuracy of all aspects of the work (All authors).
Corresponding authors
Ethics declarations
Competing interests
None of the authors have a conflict of interest to declare.
Ethical approval and consent to participate
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This study was approved by the Institutional Medical Ethics Committee of No. 1 Affiliated Hospital, Wenzhou Medical University (Approval document #2016045). Informed consent was obtained from all individual participants included in the study.
Consent for publication
Not applicable.
Trial registration
Chinese Clinical Trial Registry, ChiCTR1800019239; registered on 1 November 2018-retrospectively registered, http://www.chictr.org.cn/listbycreater.aspx, more than a month after the start of the experiment. The delay was due to lack of experience regarding trail, registration with a data sharing website.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Chen, J., Li, Y., **a, N. et al. White matter alterations in heart-kidney imbalance insomnia and Jiao-Tai-Wan treatment: A diffusion-tensor imaging study. Brain Imaging and Behavior 16, 1803–1812 (2022). https://doi.org/10.1007/s11682-022-00653-6
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11682-022-00653-6